Luminex

Diasorin announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the company’s new LIAISON PLEX^® platform as well as its first panel of tests, the LIAISON PLEX^® Respiratory Flex Assay.

Get to market faster with LuminexPLORE Lab custom assay development and multiplex testing services. Our team of scientists combine technical precision with industry-leading xMAP® and xTAG® technologies to produce highly specific proteomic and genomic multiplex assays.

In this video, Dr. Charles Rosser, a board-certified urologist discusses the development of Oncuria for the early detection of bladder cancer.

Bio-Techne's Quantist Luminex data analysis software helps you extract insight from complexity. Use this software to evaluate the quality of your standards, controls, and unknowns. Evaluate the long-term consistency of your Luminex data by using Quantist to make inter-assay comparisons.

Multiplexing allows multiple biological target analytes to be simultaneously examined and quantified in a single sample. It’s a technique widely used by scientific researchers of all disciplines and provides many benefits including maximizing the use of limited samples whilst minimizing experimental variability.

In this article, we will discuss how the use of different high-throughput screening methods can help to accelerate the drug discovery process.

Bio-Techne multiplexing tools provide fast, dependable, and highly accurate results with minimal sample waste. Our multiplexing tools offer high throughput testing solutions for timely and reliable research. A large variety of species and analytes will ensure these reproducible and cost-effective assays produce the highest quality results while saving you time. With laboratory applications including biomarker detection and validation, Bio-Techne multiplexing assays are sure to enhance your research.